DK139881A - Fremgangsmaade til fremstilling af chirale hydantoiner - Google Patents

Fremgangsmaade til fremstilling af chirale hydantoiner

Info

Publication number
DK139881A
DK139881A DK139881A DK139881A DK139881A DK 139881 A DK139881 A DK 139881A DK 139881 A DK139881 A DK 139881A DK 139881 A DK139881 A DK 139881A DK 139881 A DK139881 A DK 139881A
Authority
DK
Denmark
Prior art keywords
procedure
manufacture
hydantoins
chiral
chiral hydantoins
Prior art date
Application number
DK139881A
Other languages
Danish (da)
English (en)
Inventor
R Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK139881A publication Critical patent/DK139881A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
DK139881A 1980-03-28 1981-03-27 Fremgangsmaade til fremstilling af chirale hydantoiner DK139881A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/135,137 US4286098A (en) 1980-03-28 1980-03-28 Process for the preparation of chiral hydantoins

Publications (1)

Publication Number Publication Date
DK139881A true DK139881A (da) 1981-09-29

Family

ID=22466719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK139881A DK139881A (da) 1980-03-28 1981-03-27 Fremgangsmaade til fremstilling af chirale hydantoiner

Country Status (12)

Country Link
US (1) US4286098A (ja)
EP (2) EP0037672B1 (ja)
JP (2) JPS56152483A (ja)
AR (1) AR225498A1 (ja)
DE (1) DE3174610D1 (ja)
DK (1) DK139881A (ja)
ES (1) ES8204737A1 (ja)
GR (1) GR74481B (ja)
HK (1) HK99287A (ja)
IE (1) IE52337B1 (ja)
MY (1) MY8800093A (ja)
SG (1) SG69987G (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58124788A (ja) * 1982-01-20 1983-07-25 Eisai Co Ltd 光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
US4528387A (en) * 1982-11-10 1985-07-09 Pfizer Inc. Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4431828A (en) * 1982-11-10 1984-02-14 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil
US4435578A (en) * 1982-11-10 1984-03-06 Pfizer Inc. Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4620019A (en) * 1984-08-23 1986-10-28 Pfizer Inc. S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil
JPS6172762A (ja) * 1984-09-17 1986-04-14 Kanegafuchi Chem Ind Co Ltd 光学活性ヒダントイン類の製造法
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
JPH05508386A (ja) * 1989-02-10 1993-11-25 ワシントン　リサーチ　ファンデション 免疫調整剤
US5151544A (en) * 1990-05-25 1992-09-29 Alcon Laboratories, Inc. Intermediates in the preparation of chiral spirofluorenehydantoins
US20040002615A1 (en) * 2002-06-28 2004-01-01 Allen David Robert Preparation of chiral amino-nitriles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4093799A (en) * 1977-07-01 1978-06-06 Morton-Norwich Products, Inc. N-arylidene-4-chromanamines

Also Published As

Publication number Publication date
US4286098A (en) 1981-08-25
EP0037672A2 (en) 1981-10-14
IE810709L (en) 1981-09-28
EP0145895A1 (en) 1985-06-26
ES500744A0 (es) 1982-01-16
JPS56152483A (en) 1981-11-26
GR74481B (ja) 1984-06-28
EP0037672B1 (en) 1986-05-14
JPS6340433B2 (ja) 1988-08-11
ES8204737A1 (es) 1982-01-16
HK99287A (en) 1987-12-31
IE52337B1 (en) 1987-09-16
SG69987G (en) 1988-02-19
DE3174610D1 (en) 1986-06-19
JPS63253086A (ja) 1988-10-20
AR225498A1 (es) 1982-03-31
EP0145895B1 (en) 1987-03-04
MY8800093A (en) 1988-12-31
EP0037672A3 (en) 1983-08-24

Similar Documents

Publication Publication Date Title
DK480381A (da) Fremgangsmaade til fremstilling af carbostyrilforbindelser
DK65882A (da) Fremgangsmaade til fremstilling af substituerede phosphonamider
DK31282A (da) Fremgangsmaade til fremstilling af aromatiske urethaner
DK450083D0 (da) Fremgangsmade til fremstilling af antibakterielle forbindelser
DK150903C (da) Analogifremgangsmaade til fremstilling af benzisoselenazoloner
DK276582A (da) Fremgangsmaade til fremstilling af cephemderivater
DK139881A (da) Fremgangsmaade til fremstilling af chirale hydantoiner
DK30781A (da) Fremgangsmaade til fremstilling af triazolidinderivater
DK63683A (da) Fremgangsmaade til fremstilling af cephemderivater
DK335882A (da) Fremgangsmaade til fremstilling af cephemderivater
DK108783A (da) Fremgangsmaade til fremstilling af triglycerider
DK427083A (da) Fremgangsmaade til fremstilling af cephemderivater
DK216681A (da) Fremgangsmaade til fremstilling af antitumormidler
DK364481A (da) Fremgangsmaade til fremstilling af caprylolactamer
DK46781A (da) Fremgangsmaade til fremstilling af antirhinovirusmidler
DK296281A (da) Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK425582A (da) Fremgangsmaade til fremstilling af amider
DK579181A (da) Fremgangsmaade til fremstilling af diarylthiophener
DK343381A (da) Fremgangsmaade til fremstilling af urinstof
DK507282A (da) Fremgangsmaade til fremstilling af azinorifamycin forbindelser
DK437481A (da) Fremgangsmaade til fremstilling af nye kemiske forbindelser
DK480482A (da) Fremgangsmaade til syntese af alfa-chlormethylchlorformiat
DK153841C (da) Fremgangsmaade til fremstilling af ranitidin
DK12581A (da) Fremgangsmaade til fremstilling af kijanimicin
DK273183A (da) Fremgangsmaade til fremstilling af amidiner

Legal Events

Date Code Title Description
PBP Patent lapsed
AHS Application shelved for other reasons than non-payment